Catalyst Wire Dossier Catalyst Wire Dossier

bumetanide oral liquid formulation

bumetanide · Institut de Recherches Internationales Servier
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bumetanide oral liquid formulation, covering 2023-06-05 to 2023-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder. [Phase 3]

See pricing